Longtime Vertex CEO Jeffrey Leiden is taking on a new role.
Leiden has been appointed chairman of Tmunity’s board of directors, the company announced Monday. The move comes about a year and a half after Leiden announced he’d be stepping down from his position at Vertex.
Vertex saw immense growth under Leiden, leading the company from its exit out of hepatitis C, when cures were moving in, and into cystic fibrosis. The company’s cystic fibrosis triple combo therapy Trikafta is already its best-seller, reaching the distinction just six weeks after launch and recording the strongest first quarter of sales for any drug, per some estimates.
The Link LonkJanuary 25, 2021 at 10:57PM
https://ift.tt/3a58T5h
Covid-19 roundup: Moderna doubles down on Covid-19 with new booster trials; Australia plans domestic production of AstraZeneca vaccine amid distribution lag - Endpoints News
https://ift.tt/2DVP6sH
No comments:
Post a Comment